What type of study is this?

This is a In Vitro Study study.

August 19, 2025PLoS ONEOpen Access

Characterization of multi-targeted insulin-mimetic antidiabetic peptides using in silico approaches

View Full Paper

Ask AI

Bookmark

Authors

In silico approaches revealed hypoglycemic peptides binding to key diabetic receptors, indicating potential therapeutic candidates.

Peptide P2 interacted strongly with maltase-glucoamylase and glucose transporter 1, suggesting effective binding dynamics.
Hypoglycemic peptides from plant sources were analyzed for their binding interactions across ten diabetic protein receptors.
Docking studies indicated that peptides P2 and P6 exhibited superior binding patterns with significant energy scores against selected targets.
Findings imply that insulin-mimetic peptides may serve as therapeutic alternatives, but require further validation for clinical use.

Bilal et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

August 19, 2025PLoS ONEOpen Access

View Full Paper

Ask AI

Bookmark

Authors

In silico approaches revealed hypoglycemic peptides binding to key diabetic receptors, indicating potential therapeutic candidates.

Peptide P2 interacted strongly with maltase-glucoamylase and glucose transporter 1, suggesting effective binding dynamics.
Hypoglycemic peptides from plant sources were analyzed for their binding interactions across ten diabetic protein receptors.
Docking studies indicated that peptides P2 and P6 exhibited superior binding patterns with significant energy scores against selected targets.
Findings imply that insulin-mimetic peptides may serve as therapeutic alternatives, but require further validation for clinical use.

Bilal et al. (2025) studied this question.

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark